Navigation Links
MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
Date:8/23/2007

GAITHERSBURG, Md., Aug. 23 /PRNewswire/ -- MedImmune, Inc. today announced that in a Phase 3 study, motavizumab was shown to reduce hospitalizations due to respiratory syncytial virus (RSV) by 83 percent as compared to placebo (8.3 percent in placebo arm vs. 1.4 percent in motavizumab; p<0.001), as the trial's primary endpoint. In addition, the trial showed a 71-percent reduction in the incidence of RSV-specific lower respiratory infections (LRIs) requiring outpatient management (9.5 percent in placebo group and 2.8 percent in the motavizumab group; p<0.001), which was a secondary endpoint.

Motavizumab is an investigational monoclonal antibody (MAb) being evaluated for its potential to prevent serious disease caused by RSV in high-risk pediatric patients. This Phase 3 trial involved 1,410 full-term infants less than six months of age in two Native American populations. In previous medical studies these populations were shown to have high rates of hospitalization due to RSV.

The randomized (2:1), double-blind study was designed to compare monthly intramuscular injections of motavizumab against placebo. After an interim analysis conducted by an independent data safety monitoring committee, the study was unblinded early due to statistical evidence demonstrating that motavizumab reduced RSV hospitalizations and LRIs requiring outpatient medical management within this population. Kate O'Brien, M.D., associate professor at the Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, served as the study's principal investigator.

"We are pleased with the results of this study which support the positive results seen in our Phase 3 pivotal trial comparing motavizumab and Synagis(R) (palivizumab) that were previously reported at the Pediatric Academic Societies meeting in May 2007," said Genevieve Losonsky, M.D., vice president, clinical development, infectious disease, MedImmune.

Motavizumab was well tolerated in these
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
4. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
7. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
8. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
9. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat
10. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
11. Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014 Creekridge Capital, ... added 14 new vendors so far in 2014 ... Creekridge,s newest vendors are from both the healthcare ... organizations to large, well-known multi-national companies. Each of ... suite of financing products including: standard leasing products, ...
(Date:7/23/2014)... MINNEAPOLIS , July 23, 2014  Nonin Medical, ... leader in noninvasive medical monitoring, announced today that ... OEM, has been elected Chairman of the American Telemedicine ... Board of Directors. The ATA is the ... advanced remote medical technologies. The ATA and its diverse ...
(Date:7/23/2014)... NEW YORK , July 23, 2014  When it ... David Wagner is ready to roll out the red ... to welcome an influx of HAL 9000-like robots into our ... US right now, there,s a pressing need to apply new ... in: The worldwide market for medical robotics is expected to ...
Breaking Medicine Technology:Creekridge Capital Signs Several New Vendor Partners 2Nonin Medical Announces that Mark VanderWerf has been Elected Chairman of the American Telemedicine Association's Industry Council 2
... large,randomized clinical trial for patients with newly diagnosed,multiple ... has,shown that the use of a low dose ... lenalidomide (Revlimid ®),is associated with improved survival when ... higher, standard dose of,dexamethasone. The clinical trial was ...
... and lifelong prescriptions. Millions of patients have,discovered that ... heart,operations may be having more of a detrimental ... publicly acknowledged. Recent,articles in medical journals suggest that ... blood thinners, they,could more than double their risk ...
Cached Medicine Technology:Low-Dose Steroid Combined With Lenalidomide Prolongs Survival,Compared With High-Dose Steroid for Multiple Myeloma Treatment 2Low-Dose Steroid Combined With Lenalidomide Prolongs Survival,Compared With High-Dose Steroid for Multiple Myeloma Treatment 3New Cardioprotective Drug Could Provide Boost For Post-Bypass,Surgery Heart Health 2
(Date:7/23/2014)... University of Exeter has developed a simple, cheap ... fatal lung disease which attacks immune deficient individuals ... recipients. , The lateral-flow device (LFD), created by ... notoriously difficult to diagnose disease caused by the ... Invasive aspergillosis is a leading cause of death ...
(Date:7/23/2014)... New York (PRWEB) July 23, 2014 ... use of a power morcellator ( http://www.injurybeacon.com/power-morcellator/ ) ... and other cancers throughout a woman’s body, Bernstein Liebhard ... 22nd in the Journal of the American Medical Association, ... a power morcellator at 500 U.S. hospitals from 2006 ...
(Date:7/23/2014)... NY, July 24, 2014) If past experience is ... State are about to get a lot more recognition ... already on the books allowing NPs to provide primary ... patient care and better relationships with physicians and administrators, ... study from Columbia University School of Nursing, published in ...
(Date:7/23/2014)... Reinberg HealthDay Reporter ... and overweight American children and teens look in the ... health officials reported Wednesday. "Being overweight or obese ... blood pressure, high cholesterol and diabetes," said lead researcher ... for Disease Control and Prevention,s National Center for Health ...
(Date:7/23/2014)... AURORA, Colo. (PRWEB) July 23, 2014 ... introduces a woman from Milwaukee, Wis. who was physically ... at age 21, she ultimately made the heart-wrenching decision ... has haunted her for the past 18 years, and ... in the process. , Featuring a unique, non-competitive approach ...
Breaking Medicine News(10 mins):Health News:New device detects deadly lung disease 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 4Health News:New York law offers nurses more recognition, responsibility 2Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 2Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 3Health News:“Extreme Weight Loss”: Cassie’s journey begins at the University of Colorado Anschutz Health and Wellness Center 2
... CINCINNATIUniversity of Cincinnati (UC) researchers have discovered that ... type of pediatric brain tumorleading them to believe ... limiting tumor progression and improving patients, overall outcome. ... March 2009 edition of Endocrinology . , ...
... A recent study conducted by Northwestern Memorial ... discussions increase staff communication and teamwork, thus reducing the ... in the February issue of Archives of Surgery ... in the airline industry as Crew Resource Management, which ...
... the World Health Organization Commission on Social Determinants ... for Society and Health at University College London, ... talk, "Social Determinants of Health: Global Evidence and ... organized by Martin Seligman, University of Pennsylvania professor ...
... Saint Louis University researchers found that weight loss of at ... disease known as nonalcoholic steatohepatitis (NASH), a finding that will ... likely to improve their livers. The finding comes from a ... and Alli), which did not itself improve liver disease. , ...
... Quantum Group, Inc. (NYSE Amex: QGP ) ... electronic Record) demonstrations presented at the 2009 Pri-Med South ... crowds throughout the 3-day event.Pete Martinez, Quantum Senior Vice ... team responsible for the development of PWeR. Martinez ...
... Cold Remedy Now Available in U.S. -NEW YORK, Feb. 17 ... year again when sneezing, stuffy noses, sore throats and coughs ... spend over $3 billion in over-the-counter cold remedies in the ... Yet, according to the Centers of Disease Control, Americans ...
Cached Medicine News:Health News:Estrogen found to increase growth of the most common childhood brain tumor 2Health News:Hospitals apply lessons learned in the airline industry to improve operating room safety 2Health News:Weight loss improves fatty liver disease, researchers find 2Health News:The Quantum Group Announces Standing-Room-Only PWeR(TM) Demonstrations at Pri-Med South Expo 2Health News:The Quantum Group Announces Standing-Room-Only PWeR(TM) Demonstrations at Pri-Med South Expo 3Health News:Got Cold Symptoms? Five Ways to Stay Healthy This Season 2Health News:Got Cold Symptoms? Five Ways to Stay Healthy This Season 3Health News:Got Cold Symptoms? Five Ways to Stay Healthy This Season 4
... The Featured Products are ... Mediflex and are offered ... in regular or extra ... equipped with insulation, flush ...
... Products are kept in ... are offered as 1-piece ... or extra long lengths. ... insulation, flush ports, rotating ...
... Featured Products are kept ... and are offered as ... regular or extra long ... with insulation, flush ports, ...
... The Featured Products are ... Mediflex and are offered ... in regular or extra ... equipped with insulation, flush ...
Medicine Products: